NSCLC Competitive Intelligence, One View
See your NSCLC assets against every relevant trial, MOA and competitor in minutes – not weeks. Map your NSCLC drug versus all active competitors by phase, MOA and line of therapy. Compare endpoints, patient populations and trial designs in a single CI workspace. Spot gaps in the bispecific, ADC and IO landscape before protocol finalisation or payer negotiations.
Purpose-built for oncology CI, Clinical Development, Medical Affairs and Market Access teams.
The Challenge
NSCLC is crowded. Your view of it shouldn't be.
NSCLC programmes now compete across dozens of MOAs, combinations and biomarker-defined subgroups. Trial registries, congress abstracts, MRD data and press releases move faster than internal spreadsheets can keep up.
For CI, Clinical and MA teams, this means weeks spent manually compiling NSCLC trial landscapes, conflicting versions of "the truth" across deck, spreadsheet and inbox, and limited time left for actual strategy – positioning, differentiation and payer stories.
You don't need more PDFs. You need a single, trusted NSCLC view.
Weeks wasted on manual compilation
Conflicting competitive intelligence across teams
Strategy time lost to data gathering
The Solution
A focused NSCLC lens on the global trial landscape
Knolens applies AI to normalise, connect and monitor NSCLC trial data – so your teams can answer "Who are we really competing with?" in a few clicks.
Asset-centric NSCLC views
Start from your drug name or NCT. Instantly see direct and adjacent competitors by phase, MOA, line of therapy and target population. Navigate the competitive landscape with precision and confidence.
Endpoint and design comparators
Compare primary and secondary endpoints including PFS, OS, ORR, DOR, MRD and QoL. Highlight which competitors are moving earlier in line, expanding histologies or shifting combinations to stay ahead.
Always-on monitoring
Track new NSCLC trials, amendments and key readouts tied to your assets. Receive concise digests your CI and clinical governance forums can act on immediately.
Built for teams who live inside NSCLC decisions
Competitive Intelligence / Portfolio
- Rapid competitor landscaping for pipeline and BD decisions
- "One truth" for NSCLC before governance or investment reviews
Clinical Development / Medical
- Support protocol design with up-to-date comparators
- Understand how endpoints and combinations are evolving
Get Started
Get a focused NSCLC competitive snapshot for your asset
Share the name of your NSCLC asset or NCT ID and we'll prepare a focused view of its competitive landscape – endpoints, key trials and closest competitors – to review together. Transform scattered data into actionable intelligence.
01
Connect and configure
We align on your NSCLC assets, target MOAs and geographies. Data sources are configured and quality-checked for accuracy.
02
Curated NSCLC workspaces
You receive asset-level workspaces including trials, endpoints, key competitors and timelines. Each workspace is tailored to your specific therapeutic focus.
03
Insights into your workflows
Export ready-to-use views for slides, governance documents and medical plans. Optional alerts when material NSCLC changes occur.
Why oncology teams rely on an NSCLC-first CI view
- Helped an oncology CI team cut NSCLC landscaping time from weeks to days
- Supported protocol and positioning discussions across multiple EGFR and bispecific programmes
- Designed for regulated environments with traceable sources and transparent assumptions
One focused overview to see if this is useful for your team.